Shawver Laura

CIK 00015518915 companiesCARY, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001551891

Recent Transactions

50 trades

Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2025-06-25+30,000→ 30,000 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-04-07$12.30/sh−50,002→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-04-07−27,493→ 24,062 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-04-07$4.85/sh+22,509→ 232,855 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-04-07−22,509→ 51,555 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-04-07$4.85/sh+27,493→ 260,348 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-03-06$4.85/sh+49,600→ 259,946 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-03-06−49,600→ 74,064 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-03-06$11.21/sh−49,600→ 210,346 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-03-05$11.00/sh−400→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-03-05−400→ 123,664 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-03-05$4.85/sh+400→ 210,746 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-02-03−9,064→ 0 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-02-03$4.85/sh+40,936→ 260,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-02-03$3.15/sh+9,064→ 219,410 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-02-03−40,936→ 124,064 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-02-03$12.31/sh−50,000→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-01-06−50,000→ 9,064 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-01-06$3.15/sh+50,000→ 260,346 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-01-06$11.10/sh−50,000→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-04$3.15/sh+14,772→ 225,118 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-04−14,772→ 59,064 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-04$13.75/sh−14,772→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-03$3.15/sh+62,378→ 298,330 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-03−62,378→ 73,836 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-03$1.27/sh+25,606→ 235,952 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-03$13.26/sh−87,984→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-03−25,606→ 0 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$13.55/sh−96,343→ 211,247 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$1.27/sh+67,616→ 277,962 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$1.27/sh+29,628→ 307,590 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$14.34/sh−901→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-02−67,616→ 0 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-02−29,628→ 25,606 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2024-06-20+40,000→ 40,000 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2024-06-03+102,225→ 102,225 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2023-09-01−2,997→ 0 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-09-01$1.27/sh+2,997→ 213,343 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-09-01$1.27/sh+97,003→ 310,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2023-09-01−97,003→ 55,235 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-09-01$7.71/sh−100,000→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-04$1.27/sh+18,897→ 229,243 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2023-08-04−18,897→ 2,997 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-04$7.06/sh−18,897→ 210,346 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-03$7.01/sh−26,107→ 210,346 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2023-08-03−26,017→ 21,894 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-03$1.27/sh+26,107→ 236,453 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-02$1.27/sh+36,281→ 246,627 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2023-08-02−36,281→ 48,001 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-02$7.09/sh−36,281→ 210,346 total

Companies

Recent Filings

Address

1255 CRESCENT GREEN DRIVE SUITE 250

CARY, NC, 27518

View on SEC.gov